HER
HER inhibitors are compounds that block the activity of Human Epidermal Growth Factor Receptors, particularly HER2, which is overexpressed in certain breast cancers and other malignancies. Inhibition of HER signaling pathways is a key strategy in targeted cancer therapies. At CymitQuimica, we offer HER inhibitors to support your research in oncology, targeted therapies, and cell signaling.
Found 6 products of "HER"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
ABP-102
ABP-102 (CT P72) is a bispecific t-cell adduct (BiTE) that acts as a CD3 modulator and selective HER2 modulator for targeting HER2 overexpressing tumors.Color and Shape:Odour LiquidPanomifene HCl
CAS:Panomifene HCl is a selective anti-estrogenic compound with antitumor activity for the treatment of breast cancer.Formula:C25H25ClF3NO2Purity:99.53%Color and Shape:SoildMolecular weight:463.92Trastuzumab β
CAS:Trastuzumab beta (ABP 980), a biosimilar McAb, targets HER2 for HER2+ breast and gastric cancer research.Color and Shape:LiquidPF-04929113 Mesylate
CAS:PF-04929113 Mesylate (SNX-5422 Mesylate), a prodrug of SNX-2112, is an orally available Hsp90 inhibitor (Kd: 41 nM) and also induces Her-2 degradation (IC50: 37Formula:C26H34F3N5O7SPurity:99% - 99.46%Color and Shape:SolidMolecular weight:617.63Ref: TM-T4342
1mg73.00€2mg95.00€5mg150.00€10mg273.00€25mg396.00€50mg583.00€100mg832.00€500mg1,684.00€1mL*10mM (DMSO)220.00€PF04929113
CAS:PF04929113 (SNX-5422), a synthetic small molecule Hsp90 inhibitor, offers potent efficacy orally for various cancers.Formula:C25H30F3N5O4Purity:99.04%Color and Shape:SolidMolecular weight:521.53Ref: TM-T6341
1mg37.00€2mg50.00€5mg79.00€10mg113.00€25mg177.00€50mg334.00€100mg500.00€1mL*10mM (DMSO)92.00€BMS 599626 2HCl
CAS:BMS 599626 2HCl (873837-23-1(HCl)) (AC480 dihydrochloride) is a selective inhibitor of HER1 and HER2 (IC50s: 20 nM and 30 nM), ~8-fold less potent to HER4, >100Formula:C27H29FN8O3Cl2Purity:99.94%Color and Shape:SoildMolecular weight:603.48
